Xiaowen He, Xuhui Dong, Yongqin Li, Yanhong Xu, Xiaoming Xia, Kehua Li, Huiru Xue, Xingwu Dong. "Ori-TTV particles enable potent in vivo CAR-T cell engineering for the treatment of hematologic malignancies and autoimmune diseasesā€ƒ2256860." The Journal of Immunology, 2026. doi:10.1093/jimmun/vkag141.366